You are viewing: US Rigid Endoscopes Market analysis
Part of: Rigid Endoscopes Market (Global)

The US Rigid Endoscopes Market was valued at $161.3 Million in 2025 and projected to reach to $194.7 Million by 2030, representing a compound annual growth rate of 3.8%. The US rigid endoscopes market is positioned for sustained growth through 2030, driven by increasing preference for minimally invasive surgical techniques that reduce patient recovery times and hospital costs.

US Rigid Endoscopes Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

US Rigid Endoscopes Market Trends and Insights

  • The US market benefits from advanced healthcare infrastructure, high adoption of minimally invasive surgical procedures, and strong reimbursement policies that support endoscopic interventions across hospitals and surgical centers.
  • Demand in the US is driven by increasing prevalence of chronic diseases, aging population demographics, and technological innovations in rigid endoscope design and imaging capabilities. The US rigid endoscopes market is characterized by the presence of established medical device manufacturers and a competitive landscape focused on product differentiation and clinical outcomes.
  • Throughout the 2025–2030 forecast period, the US market will likely see sustained growth fueled by rising surgical volumes, expansion of outpatient surgical facilities, and continued investment in healthcare technology.
  • The US regulatory environment, governed by the FDA, ensures product quality and safety, further supporting market confidence and adoption among healthcare providers..

Key Market Statistics

  • CAGR (2025-2030) 3.8% CAGR
  • Market Size, 2025 ~USD 161.3 Million
  • Forecast, 2030 ~USD 194.7 Million
  • Country US

US Rigid Endoscopes Market Overview

Market Valuation :

The US rigid endoscopes market is valued at $161.3 million in 2025, with projections reaching $194.7 million by 2030, representing steady growth in the minimally invasive surgery sector.

Growth Rate :

The US market is expanding at a CAGR of 3.8% through 2030, outpacing global growth trends and reflecting strong domestic demand for advanced surgical visualization technologies.

Healthcare Infrastructure :

Advanced US healthcare infrastructure, coupled with high adoption rates of minimally invasive procedures across hospitals and surgical centers, drives consistent market expansion and innovation.

Reimbursement Support :

Strong reimbursement policies from Medicare, Medicaid, and private insurers support endoscopic interventions, making rigid endoscopes economically viable for healthcare facilities nationwide.

US Rigid Endoscopes Market Dynamics

  • Healthcare providers across the US are investing in advanced endoscopic equipment to enhance surgical precision and patient outcomes, supported by favorable reimbursement landscapes and aging demographics requiring more surgical interventions. Key growth catalysts include technological advancements in imaging quality, integration of digital solutions, and expanding applications in orthopedic, ENT, and urological procedures.
  • The competitive landscape remains robust with established manufacturers and emerging innovators driving product development.
  • Market consolidation and strategic partnerships will likely shape the competitive dynamics as providers seek cost-effective solutions without compromising clinical performance..

Related Ecosystem

Medical Devices

Top Technologies
    Top Companies

      Key Takeaways

      • The US rigid endoscopes market is valued at $161.3 million in 2025 and is expected to reach $194.7 million by 2030, representing a 3.8% CAGR.
      • The US market is driven by high adoption of minimally invasive procedures, advanced healthcare infrastructure, and favorable reimbursement policies.
      • Aging population and rising prevalence of chronic diseases in the US are key factors fueling demand for rigid endoscopic interventions.
      • The US regulatory framework and presence of established manufacturers create a competitive, innovation-focused market environment.

      Rigid Endoscopes Market Report Scope

      Report Metric Details
      Base Year 2025
      Fastest Growing Segment NEUROENDOSCOPY (Application)
      Forecast Period 2025–2030
      Growth Rate CAGR of 4.9% from 2025 to 2030
      Largest Segment SURGICAL USAGE (Clinical Usage)
      Market Size Base Year (Billions) ~USD 1.83 (2025)
      Revenue Forecast (Billions) ~USD 2.32 (2030)
      Segments Covered Type, Clinical Usage, Application, End User

      US Rigid Endoscopes Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Type

      • Arthroscopes
      • Cystoscopes
      • Gynecology Endoscopes
      • Laparoscopes
      • Neuroendoscopes
      • Other Rigid Endoscopes
      • Urology Endoscopes

      By Clinical Usage

      • Diagnostic Usage
      • Surgical Usage

      By Application

      • Arthroscopy
      • Laparoscopy
      • Neuroendoscopy
      • Other Applications
      • Urology
      • Urology Endoscopy

      By End User

      • Ambulatory Surgery Centers
      • Clinics
      • Hospitals
      • Other End Users

      US: RIGID ENDOSCOPES MARKET, BY END USER, 2023–2030

      Segment20232024202520262027202820292030CAGR (%)
      AMBULATORY SURGERY CENTERS77.781.685.389.49499.1104.81115.4
      CLINICS38.139.640.942.444.14648.150.44.3
      HOSPITALS315.6327.2337.4349.2362.4377.3393.94124.1
      OTHER END USERS2930.231.332.63435.637.339.24.6
      TOTAL460.5478.6494.9513.5534.4558584.1612.64.4

      Target Audience

      • Medical Device Manufacturers : Manufacturers need US market data to benchmark product performance, identify market gaps, optimize pricing strategies, and develop targeted go-to-market approaches for rigid endoscope portfolios.
      • Healthcare Facility Administrators : Hospital and surgical center leaders require market insights to justify capital equipment investments, evaluate supplier options, and align procurement decisions with reimbursement trends and clinical outcomes.
      • Investment & Private Equity Firms : Investors need comprehensive US market analysis to evaluate acquisition targets, assess growth potential, identify consolidation opportunities, and make informed funding decisions in the medical device sector.
      • Healthcare Consultants & Analysts : Consultants require detailed US market data to support client advisory services, competitive benchmarking, market entry strategies, and long-term business planning in the endoscopy market.
      • Procurement & Supply Chain Professionals : Supply chain leaders need market intelligence to negotiate supplier contracts, forecast demand, identify alternative vendors, and optimize inventory management for rigid endoscope equipment.

      Key Companies in the US Rigid Endoscopes Market

      CompanyHQOwnershipStrongest segments
      OLYMPUS CORPORATIONJapanPublic CompanyLaparoscopes,Cystoscopes,Arthroscopes,
      STRYKERUnited StatesPublic CompanyLaparoscopes,Arthroscopes,Cystoscopes,
      SMITH+NEPHEWUnited KingdomPublic CompanyLaparoscopes,Arthroscopes,Cystoscopes,
      MEDTRONICIrelandPublic CompanyLaparoscopes,Arthroscopes,Cystoscopes,
      NIPROJapanPublic CompanyLaparoscopes,Arthroscopes,Cystoscopes,
      CONMED CORPORATIONUnited StatesPublic CompanyLaparoscopes,Arthroscopes,Cystoscopes,
      FUJIFILM CORPORATIONJapanPublic CompanyLaparoscopes,Arthroscopes,Cystoscopes,
      HOLOGIC, INC.United StatesPrivate CompanyLaparoscopes,Arthroscopes,Cystoscopes,

      OLYMPUS CORPORATION

      Olympus Corporation is a Japanese public company founded in 1919 with 28,138 employees. The company operates as a diversified manufacturer and technology provider across multiple industrial sectors.

      STRYKER

      Stryker is a United States-based public company founded in 1941 with 56,000 employees. The company is a leading provider of medical devices and surgical equipment.

      SMITH+NEPHEW

      Smith+Nephew is a United Kingdom-based public company founded in 1856 with 16,988 employees. The company manufactures and distributes medical devices and healthcare products.

      MEDTRONIC

      Medtronic is an Ireland-based public company founded in 1949 with 95,000 employees. The company is a global leader in medical technology, services, and solutions.

      NIPRO

      Nipro is a Japanese public company founded in 1947 with 38,593 employees. The company manufactures and distributes medical devices and pharmaceutical products.

      CONMED CORPORATION

      ConMed Corporation is a United States-based public company founded in 1970 with 3,900 employees. The company manufactures and distributes surgical devices and equipment.

      FUJIFILM CORPORATION

      Fujifilm Corporation is a Japanese public company founded in 1934 with 73,526 employees. The company operates across imaging, medical systems, and industrial technology sectors.

      HOLOGIC, INC.

      Hologic, Inc. is a United States-based private company founded in 1985 with 7,070 employees. The company develops and manufactures medical diagnostic and surgical devices.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise US market valuation ($161.3M in 2025) and verified growth projections through 2030, enabling accurate financial forecasting and investment decision-making for your organization.
      • Competitive Landscape Intelligence : Understand the US-specific competitive dynamics, market consolidation trends, and strategic positioning of key players to identify partnership and acquisition opportunities in the rigid endoscopes sector.
      • Reimbursement & Regulatory Insights : Access detailed analysis of US Medicare, Medicaid, and private insurance reimbursement policies affecting rigid endoscope adoption, pricing strategies, and market accessibility across healthcare facilities.
      • End-User Demand Analysis : Gain insights into hospital and surgical center procurement patterns, procedure volume trends, and technology adoption rates specific to the US market to optimize sales and marketing strategies.
      • Growth Driver Identification : Identify key US-specific growth catalysts including aging demographics, minimally invasive procedure expansion, and technological innovations to capitalize on emerging market opportunities.

      Frequently asked questions

      What is the current size of the US rigid endoscopes market?

      The US rigid endoscopes market is valued at $161.3 million in 2025 and is projected to grow to $194.7 million by 2030.

      What is the growth rate of the US rigid endoscopes market?

      The US rigid endoscopes market is expected to grow at a compound annual growth rate (CAGR) of 3.8% from 2025 to 2030.

      What factors are driving growth in the US rigid endoscopes market?

      Key growth drivers in the US include increasing adoption of minimally invasive surgical procedures, an aging population, rising prevalence of chronic diseases, technological innovations, and strong healthcare reimbursement policies.

      Which applications dominate the US rigid endoscopes market?

      The US rigid endoscopes market is dominated by applications in otolaryngology, urology, gynecology, and arthroscopy, with hospitals and surgical centers being the primary end-users.

      How does the US market compare to global trends?

      The US rigid endoscopes market grows at 3.8% CAGR, slightly below the global average of 4.9%, reflecting the mature nature of the US healthcare market and high baseline adoption rates.

      RESEARCH METHODOLOGY

      The research study involved major activities in estimating the current market size for the rigid endoscopes market. Exhaustive secondary research was done to collect information on the rigid endoscopes industry. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, including top-down and bottom-up methods, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the rigid endoscopes market.

      Secondary Research

      The secondary research process involved the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, investor presentations, SEC filings of companies and publications from government sources, such as National Institutes of Health (NIH), US FDA, US Census Bureau, World Health Organization (WHO), International Trade Administration (ITA), Global Burden of Disease Study, and Centers for Medicare and Medicaid Services (CMS) were referred to identify and collect information for the global rigid endoscopes market study. It was also used to obtain important information about key players and market classification & segmentation, according to industry trends, and to identify key developments related to market and technology perspectives, down to the most detailed level. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various sources from both the supply and demand sides were interviewed to gather qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and other key executives from major companies and organizations in the rigid endoscopes market. The primary sources on the demand side include ambulatory surgical centers, hospitals, clinics, and other end users. Primary research was conducted to validate market segmentation, identify key players, and gather insights on industry trends and key market dynamics.

      A breakdown of the primary respondents is provided below:

      Rigid Endoscopes Market

      Notes: C-level primaries include CEOs, CFOs, COOs, and VPs.

      *Others include Sales Managers, Marketing Managers, Business Development Managers, Product Managers, Distributors, and Suppliers.

      Companies are classified into tiers based on their total revenue. The tiers are as follows:

      Tier 1 = > USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = < USD 1.00 billion

      Source: MarketsandMarkets Analysis

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      For the global market value, annual revenue figures were calculated based on the revenue mapping of major product manufacturers and OEMs active in the worldwide rigid endoscopes market. All leading product manufacturers were identified at both the global and country/regional levels. Revenue mapping was conducted for the respective business segments and subsegments for these key players. Additionally, the global rigid endoscopes market was divided into various segments and sub-segments based on:

      • List of major players operating in the products market at the regional and/or country level
      • Product mapping of various rigid endoscope manufacturers at the regional and/or country level
      • Mapping of annual revenue generated by listed major players from rigid endoscopes (or the nearest reported business unit/product category)
      • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
      • Summation of the market value of all segments/subsegments to arrive at the global rigid endoscopes market

      The data mentioned above was consolidated and supplemented with detailed inputs and analysis from MarketsandMarkets, and is presented in this report.

      Market Size Estimation (Bottom-Up & Top-down Approaches)

      Rigid Endoscopes Market

      Data Triangulation

      After determining the overall size of the global rigid endoscopes market using the methodology above, the market was segmented into several categories and subcategories. The data triangulation and market breakdown procedures were employed, wherever applicable, to complete the overall market engineering process and arrive at the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macro indicators and regional trends from both demand- and supply-side participants.

      Market Definition

      Rigid endoscopes are non-flexible, tubular instruments equipped with lens systems and light sources, enabling direct visualization and access to internal body cavities. Primarily used in minimally invasive surgeries such as laparoscopy, arthroscopy, and cystoscopy, they offer superior image quality, stability, and precision for diagnostic and therapeutic procedures.

      Stakeholders

      • Manufacturers of endoscopes and related devices
      • Suppliers and distributors of endoscopy devices
      • Hospitals, diagnostic centers, and medical colleges
      • Independent surgeons and private physicians
      • Ambulatory surgery centers
      • Teaching hospitals and academic medical centers
      • Government bodies/Municipal corporations
      • Business research and consulting service providers
      • Venture capitalists

      Report Objectives

      • To define, describe, segment, and forecast the rigid endoscopes market by type, application, end user, and region
      • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall rigid endoscopes market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the rigid endoscopes market in five main regions (along with their respective key countries), namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players in the rigid endoscopes market and comprehensively analyze their core competencies and market shares
      • To track and analyze competitive developments such as acquisitions, product launches, expansions, collaborations, agreements, partnerships, and R&D activities of the leading players in the rigid endoscopes market
      • To benchmark players within the rigid endoscopes market using the Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings

      Get the Full Rigid Endoscopes Market Report

      Full forecast, segment splits, and company analysis for all Rigid Endoscopes Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status